ESR1 and dermatomyositis: Key risk factors for malignancy in DM include diagnosis within the first 12 months, age over 44 years, rapid symptom onset, male sex, presence of dysphagia, cutaneous necrosis, elevated inflammatory markers such as ESR or CRP, and increased CK levels [2].